non-Hodgkin's lymphoma News
Most Popular non-Hodgkin's lymphoma Story
Cell Therapeutics shares soar on Phase III data
A late-stage study of Cell Therapeutics' pixantrone demonstrated its ability to significantly increase the remission rates of patients with non-Hodgkin's lymphoma. And investors moved swiftly to push Read more...
Latest Headlines
- June 2, 2009
- October 7, 2008
- September 18, 2007
- August 16, 2007
- January 7, 2007
- December 18, 2006
- October 8, 2006
- September 26, 2006
- August 3, 2006
- January 11, 2006
- October 30, 2005
- July 25, 2005
- May 25, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
